Novartis to prioritise U.S. market unfazed by drug pricing pushback
Swiss drugmaker Novartis' logo is seen at the company's plant in the northern Swiss town of Stein, Switzerland October 23, 2017. REUTERS/Arnd Wiegmann/File PhotoRegister now for FREE unlimited access to Reuters.comRegisterZURICH, Sept…